Kotak fund invests $129m in India's Biocon
Kotak Mahindra Advisors (KIA), the alternative assets arm of Kotak Mahindra Group, has committed INR 10.7bn (USD 129.4m) to Indian pharmaceuticals manufacturer Biocon to support the latter’s acquisition of a biosimilar business from global healthcare player Viatris.
KIA is investing through the Kotak Special Situations Fund, which closed in 2019 at USD 1bn. Abu Dhabi Investment Authority (ADIA) participated as the anchor LP, putting in USD 500, with additional contributions...
More on South Asia
Latest News
VC investors primed for exit with China Youzan reorganisation
Hillhouse Capital and Matrix Partners China are set for liquidity events after China Youzan, an e-commerce software-as-a-service (SaaS) business listed in Hong Kong, agreed to take full control of its key subsidiary for HKD 2.6bn (USD 334.5m).
Goldman backs Japan taxi-hailing player Go
Goldman Sachs Asset Management (GSAM) has committed JPY 10bn (USD 75m) in Series D funding to Go Inc, operator of a Japan-based taxi-hailing app.
AVCJ daily bulletin returns May 29
AVCJ’s daily bulletin will not be published on May 26 due to a public holiday in Hong Kong.
Digital bank Tyme wins funding for SE Asia, Africa expansion
Tyme Group, an emerging markets-focused digital banking group with operations in the Philippines and South Africa, has raised USD 77.8m in pre-Series C funding. A portion of the proceeds will be used for expansion into other markets in Southeast Asia.